Akoya Biosciences Inc. (AKYA)
1.09
-0.01 (-0.91%)
At close: Apr 17, 2025, 3:59 PM
1.08
-0.46%
After-hours: Apr 17, 2025, 04:05 PM EDT
-0.91% (1D)
| Bid | 1.05 |
| Market Cap | 54.3M |
| Revenue (ttm) | 81.67M |
| Net Income (ttm) | -55.37M |
| EPS (ttm) | -1.12 |
| PE Ratio (ttm) | -0.97 |
| Forward PE | -2.1 |
| Analyst | Hold |
| Ask | 1.35 |
| Volume | 319,144 |
| Avg. Volume (20D) | 310,508 |
| Open | 1.14 |
| Previous Close | 1.10 |
| Day's Range | 1.06 - 1.20 |
| 52-Week Range | 1.01 - 4.65 |
| Beta | 1.33 |
About AKYA
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Apr 16, 2021
Employees 205
Stock Exchange NASDAQ
Ticker Symbol AKYA
Website https://www.akoyabio.com
Analyst Forecast
According to 7 analyst ratings, the average rating for AKYA stock is "Hold." The 12-month stock price forecast is $3, which is an increase of 175.23% from the latest price.
Stock ForecastsNext Earnings Release
Akoya Biosciences Inc. is scheduled to release its earnings on May 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
-23%
Akoya Biosciences shares are trading lower after t...
Unlock content with
Pro Subscription
5 months ago
-2.49%
Akoya Biosciences shares are trading lower after the company reported worse-than-expected Q3 financial results.
